NCT04270149View on ClinicalTrials.gov

Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

PHASE1RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2025

Study Completion Date

August 1, 2027

Conditions

Breast Cancer

Interventions

BIOLOGICAL

ESR1 peptide vaccine

ESR1 peptides plus Montanide and GM-CSF

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

All Listed Sponsors

lead

Herbert Lyerly

OTHER